EUVIMEDEUVIMED entdecken
Open Access

Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing

Kyeryoung Lee iD, Zongzhi Liu iD, Qing Huang iD, David Corrigan iD, Iftekhar Kalsekar iD, Tomi Jun iD, Gustavo Stolovitzky iD, William K Oh iD, Ravi Rajaram, Xiaoyan Wang

JCO Clinical Cancer Informatics · 2025-04 · (9)

DOI: 10.1200/cci-24-00227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2025-04. Verfasst von Kyeryoung Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: GeneDx (Sema4), Stamford, CT. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Electronic Health Records, Natural Language Processing, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Recurrences after curative resection in early-stage and locoregionally advanced non–small cell lung cancer (NSCLC) are common, necessitating a nuanced understanding of associated risk factors. This study aimed to establish a natural language processing (NLP) system to efficiently curate recurrence data in NSCLC and analyze risk factors longitudinally. PATIENTS AND METHODS Electronic health records of 6,351 patients with NSCLC with >700,000 notes were obtained from Mount Sinai's data sets. A deep learning–based customized NLP system was developed to identify cohorts experiencing recurrence. Recurrence types and rates over time were stratified by various clinical features. Cohort description analysis, Kaplan-Meier analysis for overall recurrence-free survival (RFS) and distant metastasis-free survival (DMFS), and Cox proportional hazards analysis were performed. RESULTS Of 1,295 patients with stage I–IIIA NSCLC with surgical resections, 336 patients (25.9%) experienced recurrence, as identified through NLP. The NLP system achieved a precision of 94.3%, a recall of 93%, and an F1 score of 93.5. Among 336 patients, 52.4% had local/regional recurrences, 44% distant metastases, and 3.6% unknown recurrence. RFS rates at years 1-5 were 93%, 81%, 73%, 67%, and 61%, respectively (96%, 89%, 84%, 80%, and 75% for distant metastasis). Stage-specific RFS rates at year 5 were 73% (IA), 62% (IB), 47% (IIA), 46% (IIB), and 20% (IIIA). Stage IB patients had a significantly higher likelihood of recurrence versus stage IA (adjusted hazard ratio [aHR], 1.63; P = .02). The RFS was lower in patients with clinically significant TP53 alteration ( v TP53 -negative or unknown significance), affecting overall RFS (aHR, 1.89; P = .007) and DMFS (aHR, 2.47; P = .009) among stage IA/IB patients. CONCLUSION Our scalable NLP system enabled us to generate real-world insights into NSCLC recurrences, paving the way for predictive models for preventing, diagnosing, and treating NSCLC recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungElectronic Health RecordsNatural Language ProcessingLung NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedNeoplasm StagingAgedRisk FactorsDeep LearningPrognosis

Autor:innen und Institutionen

  • GeneDx (Sema4), Stamford, CT.
  • Lung Cancer Initiative, Johnson & Johnson, New Brunswick, NJ.
  • Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

ORCID-Profile: Kyeryoung Lee, Zongzhi Liu, Qing Huang, David Corrigan, Iftekhar Kalsekar, Tomi Jun, Gustavo Stolovitzky, William K Oh

Zitieren

APA

Lee, K., Liu, Z., Huang, Q., Corrigan, D., Kalsekar, I., Jun, T., Stolovitzky, G., Oh, W. K., Rajaram, R., & Wang, X. (2025). Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-24-00227

Vancouver

Lee K, Liu Z, Huang Q, Corrigan D, Kalsekar I, Jun T, et al. Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-24-00227

BibTeX
@article{Lee2025,
  author = {Lee, Kyeryoung and Liu, Zongzhi and Huang, Qing and Corrigan, David and Kalsekar, Iftekhar and Jun, Tomi and Stolovitzky, Gustavo and Oh, William K and Rajaram, Ravi and Wang, Xiaoyan},
  title = {Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing},
  journal = {JCO Clinical Cancer Informatics},
  year = {2025},
  number = {9},
  doi = {10.1200/cci-24-00227}
}
Kostenlos starten →